The Business Case For Electronic GxP Management

Quality systems run on spreadsheets, paper, and aging legacy tools cost more than most GxP organizations account for. This brochure makes the business case for electronic quality management, pairing common objections to adoption with direct rebuttals on recalls, data integrity, validation burden, and budget. It features Sion Wyn, GAMP SIG expert and Managing Director at Conformity, who assisted the FDA with its re-examination of 21 CFR Part 11 and argues that regulators want less line-by-line compliance and more risk-based thinking. A side-by-side comparison of the route to market under manual and integrated systems adds further context.
Explore the arguments and the customer results cited to see how the case is built.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.